GSK
Sustainability Report and Carbon Intensity Rankings
Is GSK doing their part?
Their DitchCarbon score is 50
GSK has a DitchCarbon Score of 50, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, which is a measure of how much carbon emissions are produced relative to their activity. A score of 50 suggests that GSK has room for improvement in reducing its carbon intensity to enhance its environmental performance.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
GSK, a company in the industrial manufacturing sector, has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
GSK is situated in the United Kingdom, which has a very low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by reducing its carbon footprint.
Unlock 30+ emissions data points on GSK
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on GSK
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
8.71%
...this company is doing 8.71% better in emissions than the industry average.
GSK, short for GlaxoSmithKline, is a prominent player in the global healthcare industry, headquartered in Brentford, UK. Founded in 1830, the company specializes in pharmaceuticals, vaccines, and consumer healthcare, with a focus on innovative product development. GSK is renowned for its contributions to combating priority diseases such as HIV/AIDS, tuberculosis, and malaria, and offers a diverse portfolio of consumer brands like Sensodyne and Panadol.
Good news, GSK has set science-based targets for sustainability
GSK has established Science Based Targets initiative (SBTi) commitments to significantly reduce its greenhouse gas emissions from company operations, aligning with the ambitious goal of limiting global warming to 1.5°C. This involves a rigorous approach to cutting emissions across their direct operations and energy use.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.